Newsroom
Lovelace Medical Group Physician Publishes Multi-Center Study on Anticoagulant Therapy
Albuquerque, NM – June 1, 2006 Lovelace Medical Group is proud to announce that Dr. Alex Spyropoulos, Medical Director, Clinical Thrombosis Center at Lovelace Medical Center-Gibson, has published a large, multi-center study involving 14 medical centers in the United States and Canada on bridging anticoagulant therapy in patients on long-term oral anticoagulants in the June 2006 issue of the Journal of Thrombosis and Haemostasis. Lovelace Medical Center-Gibson was the lead center in the study. Dr. Mike West, Cardiology, Lovelace Medical Center-Gibson, was the local co-investigator. Lovelace Respiratory Research Institute was the lead coordinating center.
Dr. Spyropoulos has also been nominated to co-author a chapter in the 8th ACCP (American College of Chest Physicians) Antithrombotic Guidelines entitled, “Management of Patients who Require Temporary Interruption of Antithrombotic Therapy.” This book is the international “gold-standard” on antithrombotic therapy and is published every three years, with the next edition due in 2007.
Additionally, the Clinical Thrombosis Center at Lovelace Medical Center-Gibson is one of the lead North American sites in a large, placebo controlled clinical study on bridging anticoagulant therapy that has been submitted to the National Institutes of Health for funding. Final results for funding will be announced in June.
Lovelace Health System comprises four acute care hospitals, a rehabilitation hospital, the Lovelace Health Plan, S.E.D. Medical Laboratories, Lovelace Medical Group and 15 neighborhood health care centers in Albuquerque, Rio Rancho and Santa Fe. << back |